TAKE Solutions, ACI, and OnSphere Merge to Create TAKE Solutions, Global Life Sciences and the OneClinical Brand
OneClinical Provides a Full Spectrum of Software Products and Services for the Regulated Life Sciences Industry.
Princeton, NJ-June 12, 2006-Today TAKE Solutions, Inc. announced the formation of the OneClinical™ brand of life sciences offerings as part of its merger with Applied Clinical Intelligence (Philadelphia, PA) and OnSphere Corporation (Raleigh, NC). OneClinical combines a full spectrum of proven data and document management software products and services for clinical trials, drug and device development lifecycles.
"The merger of TAKE Solutions, ACI, and OnSphere enhances our ability to help our clients improve efficiencies in drug and medical device development and product safety. We can now offer our clients global scalability as well as a robust suite of regulatory-compliant process efficiency software" said Dr. Jonathan Seltzer, President, ACI & Chief Medical Officer, TAKE Solutions Global Life Sciences.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Full Phase IIIb BATURA Trial Results Show Airsupra Cuts Severe Exacerbations by 47% in Mild Asthma
May 20th 2025Results from the pivotal BATURA trial show that Airsupra (albuterol/budesonide) significantly outperformed albuterol monotherapy in reducing severe asthma exacerbations and systemic corticosteroid exposure, reinforcing its role as a next-generation, anti-inflammatory rescue therapy for mild asthma patients.
